PLK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.373000E-01
Normal-vs-Stage2
1.677170E-01
Normal-vs-Stage3
5.353800E-01
Normal-vs-Stage4
6.132600E-01
Stage1-vs-Stage2
1.631010E-01
Stage1-vs-Stage3
7.369800E-01
Stage1-vs-Stage4
8.971600E-01
Stage2-vs-Stage3
4.060600E-01
Stage2-vs-Stage4
3.025600E-01
Stage3-vs-Stage4
8.544200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.163200E-01
Normal-vs-AfricanAmerican
5.167200E-01
Normal-vs-Asian
1.067210E-01
Caucasian-vs-AfricanAmerican
4.373200E-01
Caucasian-vs-Asian
6.979800E-01
AfricanAmerican-vs-Asian
4.757600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.019200E-01
Normal-vs-Female
2.414600E-01
Male-vs-Female
8.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.746400E-01
Normal-vs-Age(41-60Yrs)
1.920450E-01
Normal-vs-Age(61-80Yrs)
2.321400E-01
Normal-vs-Age(81-100Yrs)
2.228600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.071400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.585000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.313800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.964600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.492200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.448000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.524800E-01
Normal-vs-Daily Drinker
2.003400E-01
Normal-vs-Weekly Drinker
2.480000E-01
Normal-vs-Occasional Drinker
1.304400E-01
Normal-vs-Social Drinker
3.060200E-01
Non Drinker-vs-Daily Drinker
9.595400E-01
Non Drinker-vs-Weekly Drinker
6.198000E-01
Non Drinker-vs-Occasional Drinker
8.351400E-01
Non Drinker-vs-Social Drinker
8.454400E-01
Daily Drinker-vs-Weekly Drinker
6.494600E-01
Daily Drinker-vs-Occasional Drinker
7.847400E-01
Daily Drinker-vs-Social Drinker
8.089000E-01
Weekly Drinker-vs-Occasional Drinker
5.259200E-01
Weekly Drinker-vs-Social Drinker
5.656200E-01
Occasional Drinker-vs-Social Drinker
9.821400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.291800E-01
Normal-vs-Grade 2
7.625800E-01
Normal-vs-Grade 3
8.431600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.701170E-03
Grade 1-vs-Grade 3
1.167780E-04
Grade 1-vs-Grade 4
6.291800E-01
Grade 2-vs-Grade 3
6.568100E-02
Grade 2-vs-Grade 4
7.625800E-01
Grade 3-vs-Grade 4
8.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.227600E-01
Normal-vs-NonDiabetic
1.750990E-01
Diabetic-vs-NonDiabetic
2.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.400300E-02
Normal-vs-NoPancreatitis
2.347400E-01
Pancreatitis-vs-NoPancreatitis
1.584250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.874770E-01
Normal-vs-N1
2.055200E-01
N0-vs-N1
4.446400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.331670E-02
Normal-vs-TP53-NonMutant
3.324000E-01
TP53-Mutant-vs-TP53-NonMutant
1.62940000381084E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
